AxoGen, Inc. Loss Form

See If You Qualify For Monetary Reward

Levi & Korsinsky, LLP does not share your information with others. There is no cost or obligation for you to submit.

Submit Transaction Detail Now (Optional)

- OR -

    This submission does not create an attorney-client relationship. If we believe that you might be an appropriate lead plaintiff, we will contact you to discuss whether to establish an attorney-client relationship.

    FAX: 212-363-7171

    Levi & Korsinsky announces a class action has commenced in the USDC for the Middle District of Florida on behalf of Axogen, Inc. (NASDAQ: AXGN) shareholders who purchased shares: (1) pursuant and/or traceable to the November 2017 SPO; and/or (2) pursuant and/or traceable to the May 2018 SPO; and/or (3) between August 2, 2017 and December 18, 2018, inclusive.

    If you suffered a loss in Axogen you have until March 11, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.